(Q34477330)

2 August 2017

6 references

19 March 2019

22 March 2019

17 June 2019

10 October 2019

11 October 2019

26 August 2020

The anti-ischemic and anti-anginal properties of statins (English)

1 reference

2 August 2017

The Anti-Ischemic and Anti-Anginal Properties of Statins (English)

1 reference

10.1007/S11883-010-0147-Y

DOI

https://api.crossref.org/works/10.1007/S11883-010-0147-Y

3 September 2024

main subject

coronary artery disease

3 references

19 March 2019

22 March 2019

17 June 2019

1 reference

10 October 2019

3 references

10 October 2019

11 October 2019

26 August 2020

1 reference

11 October 2019

1 reference

26 August 2020

Joel A. Lardizabal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

3 September 2024

Prakash C. Deedwania

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

3 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21107759

3 September 2024

publication date

1 February 2011

7 references

full work available at URL

2 August 2017

19 March 2019

22 March 2019

17 June 2019

10 October 2019

11 October 2019

26 August 2020

https://link.springer.com/content/pdf/10.1007/s11883-010-0147-y.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

http://www.current-reports.com/1523-3804/13/43

3 September 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21107759/?tool=EBI

3 September 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21107759/pdf/?tool=EBI

3 September 2024

file format

Portable Document Format

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

https://europepmc.org/articles/PMC3018271

3 September 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

https://europepmc.org/articles/PMC3018271?pdf=render

3 September 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107759

http://www.springerlink.com/index/pdf/10.1007/s11883-010-0147-y

3 September 2024

1 reference

10.1007/S11883-010-0147-Y

DOI

https://api.crossref.org/works/10.1007/S11883-010-0147-Y

Current Atherosclerosis Reports

3 September 2024

published in

5 references

2 August 2017

17 June 2019

10 October 2019

11 October 2019

26 August 2020

13

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

43-50

1 reference

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

A randomized trial of therapies for type 2 diabetes and coronary artery disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Trials and tribulations associated with angina and traditional therapeutic approaches.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Optimal medical therapy with or without PCI for stable coronary disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Atherothrombosis and high-risk plaque: part I: evolving concepts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Effectiveness of statin therapy in adults with coronary heart disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

The current cost of angina pectoris to the National Health Service in the UK.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

6 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Benefits of statin treatment in cardiac syndrome-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Anti-thrombotic effects of atorvastatin--an effect unrelated to lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018271

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

27 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-010-0147-Y

Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis

21 January 2018

1 reference

12 December 2020

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

1 reference

12 December 2020

Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)

1 reference

12 December 2020

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts

1 reference

12 December 2020

An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction

1 reference

12 December 2020

Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages

1 reference

12 December 2020

Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels

1 reference

12 December 2020

10.1007/S11883-010-0147-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference